This hypothesis is further supported by our findings here that Paqr8 is spontaneously upregulated and frequently undergoes CN gain in recurrent mammary tumors in mice arising from Her2, Akt, Myc, and Wnt1-induced primary tumors subjected to oncogene downregulation, which is a genetic surrogate for targeted therapy. The gene discussed is MYC; the disease is breast cancer.